SAGE Journals Online
Advertisement
Sign In to gain access to subscriptions and/or personal tools.

 

Advanced Search

Journal Navigation

Journal Home

Subscriptions

Archive

Contact Us

Table of Contents

Advertisement

Sign In to gain access to subscriptions and/or personal tools.
Lupus
This Article
Right arrow Full Text (PDF)
Right arrow References
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to Saved Citations
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Request Reprints
Right arrow Add to My Marked Citations
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Right arrow Citing Articles via Scopus
Google Scholar
Right arrow Articles by Harigai, M
Right arrow Articles by Kashiwazaki, S
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Harigai, M
Right arrow Articles by Kashiwazaki, S
Social Bookmarking
 Add to CiteULike   Add to Complore   Add to Connotea   Add to Del.icio.us   Add to Digg   Add to Reddit   Add to Technorati   Add to Twitter  
What's this?

Responsiveness of peripheral blood B cells to recombinant CD40 ligand in patients with systemic lupus erythematosus

M Harigai

Institute of Rheumatology, Tokyo Women's Medical University, 10–22 Kawada-cho, Shinjukuku, Tokyo 162-0054, Japan; vj5m-hrgi{at}asahi-net.or.jp

M Hara

C Fukasawa

S Nakazawa

Y Kawaguchi

N Kamatani

S Kashiwazaki

Institute of Rheumatology, Tokyo Women's Medical University, Tokyo, Japan

Objective: To investigate the immunopathological significance of CD40=CD40 ligand system for B cell hyperactivation in SLE patients, the expression and the function of CD40 on B cells were compared with those of normal controls.

Methods: Expression of CD40 was evaluated by flow cytometry. DNA synthesis of B cells were measured by 3H–TdR incorporation. Antibody production was assessed by ELISA.

Results: There was no significant difference between SLE and normal controls in CD40 expression on peripheral blood B cells. Recombinant CD40 ligand-leucine zipper fusion protein (CD40L-LZ) 3significantly enhanced 3H ÿ TdR incorporation by both SLE and normal B cells–P < 0:01f. H ÿ TdR incorporation of SLE B cells without stimuli (P < 0:001) and with CD40L-LZ stimulation (p < 0:05) were significantly lower in SLE patients compared with normal controls. Active SLE B cells spontaneously produced significantly larger amounts of total IgG than normal B cells (P < 0:05). CD40L-LZ significantly increased the production of total IgG by SLE B cells (P < 0:05), but not by normal B cells. Active SLE B cells spontaneously produced IgG anti-dsDNA and IgG anti-ssDNA antibodies. CD40L-LZ significantly increased the production of these autoantibodies by SLE B cells (P < 0:05). B cells from normal controls do not produce these autoantibodies spontaneously nor in response to CD40L-LZ.

Conclusion: These findings indicate that signalling via CD40 plays an important role in B cell proliferation and autoantibody production in human SLE.

Key Words: systemic lupus erythematosus • B lymphocyte • CD40 • CD40 ligand • anti-DNA antibody

Lupus, Vol. 8, No. 3, 227-233 (1999)
DOI: 10.1191/096120399678847678


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati   Add to Twitter Twitter    What's this?


This article has been cited by other articles:


Home page
Ann Rheum DisHome page
M J Citores, I Rua-Figueroa, C Rodriguez-Gallego, A Durantez, M I Garcia-Laorden, C Rodriguez-Lozano, J C Rodriguez-Perez, J A Vargas, and P Perez-Aciego
The dinucleotide repeat polymorphism in the 3'UTR of the CD154 gene has a functional role on protein expression and is associated with systemic lupus erythematosus
Ann Rheum Dis, March 1, 2004; 63(3): 310 - 317.
[Abstract] [Full Text] [PDF]



Advertisement